BIO BIO.B Award Disclosure
Engelhardt Eva Anette · SEC Form 4 · Filed Sep 9, 2026
Award
Calculated transaction value
$0
Engelhardt Eva Anette EVP, President, Cdg
BIO BIO.B
Bio-rad Laboratories, Inc.
BIO BIO.B
Transaction date
Sep 4, 2026
Public filing date
Sep 9, 2026
Filing lag
Filed 5 days later
BIO BIO.B daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Stock Units on Bio-Rad A Common Stock
- Quantity / price
- 4,313 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0002024911-26-000006
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$329.74K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Bio-rad Laboratories, Inc. BIO BIO.B | Disposition | Sep 6, 2026 | $187.26K |
| Bio-rad Laboratories, Inc. BIO BIO.B | Exercise | Sep 6, 2026 | $0 |
| Bio-rad Laboratories, Inc. BIO BIO.B | Exercise | Sep 6, 2026 | $0 |
| Bio-rad Laboratories, Inc. BIO BIO.B | Exercise | Sep 5, 2026 | $0 |
| Bio-rad Laboratories, Inc. BIO BIO.B | Disposition | Sep 5, 2026 | $142.47K |
| Bio-rad Laboratories, Inc. BIO BIO.B | Exercise | Sep 5, 2026 | $0 |
| Bio-rad Laboratories, Inc. BIO BIO.B Current | Award | Sep 4, 2026 | $0 |